| Dr Edward Anthony Schwartz, DPM | |
|
2775 Schoenersville Rd, Bethlehem, PA 18017-7307 | |
| (610) 861-8080 | |
| (610) 807-0366 |
| Full Name | Dr Edward Anthony Schwartz |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 40 Years |
| Location | 2775 Schoenersville Rd, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366440406 | NPI | - | NPPES |
| 2170532 | Other | MAMSI | |
| 0015022770001 | Medicaid | PA | |
| 01226701 | Other | KEYSTONE HEALTH CENTRAL | |
| 328813 | Other | HEALTHAMERICA/HEALTHASSUR | |
| 0051068000 | Other | INDEPENDENCE BLUE CROSS | |
| 099505 | Other | HIGHMARK BLUE SHIELD | |
| 10761 | Other | GEISINGER HEALTH PLAN | |
| 0051068000 | Other | KEYSTONE HEALTH EAST | |
| 0091332 | Other | AETNA PPO | |
| 01226701 | Other | CAPITAL BLUE CROSS | |
| 821136 | Other | FIRST PRIORITY HEALTH | |
| 0051068000 | Other | AMERIHEALTH | |
| 1061200 | Other | CIGNA HEALTHCARE | |
| 200018139 | Other | MEDICARE RAILROAD | |
| P369814 | Other | OXFORD HEALTH PLANS | |
| 0207123 | Other | UNITED HEALTHCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | SC002781L (Pennsylvania) | Secondary |
| 208600000X | Surgery | SC002781L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Lehigh Valley Hospital - Hazleton | Hazleton, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
| Hazleton Professional Services | 8022110402 | 129 |
News Archive
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Chromatrap is a pioneer in the development of solid-state filter-based technology that significantly enhances and accelerates the important epigenetic research tool of chromatin immunoprecipitation (ChIP).
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has announced the launch of the Opera Phenix™, a next-generation, confocal, high-content screening system that will enable scientists to perform the most challenging applications with greater speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatments.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.
The Department of Health and Human Services today released the final rule for health insurance exchanges, which reportedly includes specifics about state functions and responsibilities.
› Verified 6 days ago
| Provider Name | Lehigh Valley Physician Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Chromatrap is a pioneer in the development of solid-state filter-based technology that significantly enhances and accelerates the important epigenetic research tool of chromatin immunoprecipitation (ChIP).
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has announced the launch of the Opera Phenix™, a next-generation, confocal, high-content screening system that will enable scientists to perform the most challenging applications with greater speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatments.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.
The Department of Health and Human Services today released the final rule for health insurance exchanges, which reportedly includes specifics about state functions and responsibilities.
› Verified 6 days ago
| Provider Name | Chs Professional Practice Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710987417 PECOS PAC ID: 4880591288 Enrollment ID: O20040521000334 |
News Archive
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Chromatrap is a pioneer in the development of solid-state filter-based technology that significantly enhances and accelerates the important epigenetic research tool of chromatin immunoprecipitation (ChIP).
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has announced the launch of the Opera Phenix™, a next-generation, confocal, high-content screening system that will enable scientists to perform the most challenging applications with greater speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatments.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.
The Department of Health and Human Services today released the final rule for health insurance exchanges, which reportedly includes specifics about state functions and responsibilities.
› Verified 6 days ago
| Provider Name | Hazleton Professional Services |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952464638 PECOS PAC ID: 8022110402 Enrollment ID: O20070305000195 |
News Archive
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Chromatrap is a pioneer in the development of solid-state filter-based technology that significantly enhances and accelerates the important epigenetic research tool of chromatin immunoprecipitation (ChIP).
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has announced the launch of the Opera Phenix™, a next-generation, confocal, high-content screening system that will enable scientists to perform the most challenging applications with greater speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatments.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.
The Department of Health and Human Services today released the final rule for health insurance exchanges, which reportedly includes specifics about state functions and responsibilities.
› Verified 6 days ago
| Provider Name | Lvhn Coordinated Professional Practice |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366082554 PECOS PAC ID: 2163851858 Enrollment ID: O20200331003752 |
News Archive
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Chromatrap is a pioneer in the development of solid-state filter-based technology that significantly enhances and accelerates the important epigenetic research tool of chromatin immunoprecipitation (ChIP).
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has announced the launch of the Opera Phenix™, a next-generation, confocal, high-content screening system that will enable scientists to perform the most challenging applications with greater speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatments.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.
The Department of Health and Human Services today released the final rule for health insurance exchanges, which reportedly includes specifics about state functions and responsibilities.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward Anthony Schwartz, DPM 2775 Schoenersville Rd, Bethlehem, PA 18017-7307 Ph: (610) 861-8080 | Dr Edward Anthony Schwartz, DPM 2775 Schoenersville Rd, Bethlehem, PA 18017-7307 Ph: (610) 861-8080 |
News Archive
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Chromatrap is a pioneer in the development of solid-state filter-based technology that significantly enhances and accelerates the important epigenetic research tool of chromatin immunoprecipitation (ChIP).
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has announced the launch of the Opera Phenix™, a next-generation, confocal, high-content screening system that will enable scientists to perform the most challenging applications with greater speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatments.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.
The Department of Health and Human Services today released the final rule for health insurance exchanges, which reportedly includes specifics about state functions and responsibilities.
› Verified 6 days ago